What if controlling high cholesterol no longer required daily medicines for life? No pills. No repeated injections. Just a single treatment that could reduce “bad” cholesterol for years. That futuristic idea is now becoming a real possibility — and cardiologists across the world are watching closely. A new gene-editing therapy being developed by Eli Lilly has shown promising early results in lowering LDL cholesterol, commonly known as “bad cholesterol.” The treatment recently became a major topic of discussion on an episode of NDTV Profit’s Profit 360, where leading heart specialist Dr. Rajneesh Kapoor shared his expert medical perspective on whether this could truly transform heart disease prevention.
What Is This New Cholesterol Gene Therapy?
The experimental treatment works by targeting a liver gene called PCSK9, which plays an important role in regulating cholesterol levels in the body. According to Dr. Rajneesh Kapoor, suppressing this gene allows the body to remove LDL cholesterol much more efficiently. “Gene editing looked like a distant dream a few years ago, but now it is becoming very tangible,” Dr. Kapoor explained during the NDTV Profit discussion. Unlike statins or regular cholesterol injections that require continuous use, this therapy is designed as a one-time infusion with long-lasting effects.
Early Results Are Raising Excitement
The therapy has already shown encouraging outcomes in early clinical trials involving patients with genetically high cholesterol. Key findings include: LDL cholesterol reduced by up to 62%, Effects lasting up to 18 months, Potentially stronger and longer-lasting than current medicines, Improved safety profile compared to earlier versions, For many cardiologists, these numbers are highly significant.
Dr. Kapoor noted that reducing LDL cholesterol from levels such as 200 mg/dL down to nearly 90 mg/dL could dramatically lower long-term cardiovascular risk.
Why This Could Be a Game-Changer for Heart Disease
Heart disease remains one of the leading causes of death globally, and uncontrolled cholesterol is a major contributor. According to Dr. Kapoor, one of the biggest challenges in real-world treatment is patient compliance. “Many patients stop taking cholesterol medicines after a few months once they feel better,” he said. Even with modern statins, some patients continue to experience heart attacks because existing medicines do not completely address every cholesterol-related pathway. That is why researchers are now exploring more durable and comprehensive solutions. “If cholesterol can be controlled in a long-term durable manner, we could potentially change the entire face of coronary artery disease,” Dr. Kapoor emphasized.
But Is Editing Human DNA Safe?
Despite the excitement, experts caution that gene-editing therapy still raises important safety questions. The treatment works by making highly precise modifications inside the body’s genetic framework. Scientists use special delivery systems to ensure only the targeted gene is affected. However, long-term risks remain under evaluation. According to Dr. Kapoor, unintended genetic alterations could theoretically affect other organs or cellular functions if not performed with extreme precision.
Potential concerns include: Unexpected DNA changes, Cellular abnormalities, Long-term organ effects, Unknown future complications
Still, Dr. Kapoor remains optimistic. “The process is becoming increasingly precise and foolproof with scientific advancement,” he explained.
Who May Benefit the Most?
If approved in the future, this therapy is expected to benefit specific high-risk groups first. This may include: Familial Hypercholesterolemia Patients, People born with genetically very high cholesterol levels, Individuals struggling with difficult-to-control lipid disorders, People with moderate cholesterol levels but strong risk factors for heart disease.
Dr. Kapoor also believes younger patients with inherited cholesterol disorders may especially benefit because they often require lifelong treatment from an early age, Patients With Severe Obesity & High Triglycerides, High Cardiovascular Risk Patients.
Will Patients Still Need Lifestyle Changes?
Absolutely. Even if gene-editing therapy becomes successful, doctors stress that healthy lifestyle habits will remain essential for long-term heart protection. Cardiologists still recommend Regular physical activity, Low-fat, heart-friendly diet, Weight management, Smoking cessation, Blood pressure and diabetes control, “Lifestyle modification can never be replaced,” Dr. Kapoor highlighted during the discussion.
How Expensive Could This Treatment Be?
Experts estimate the first version of the therapy could cost around $50,000 initially. However, Dr. Kapoor pointed out that lifelong medicines, repeated injections, and years of treatment also carry major financial costs over time. As technology becomes more widely available, pricing may eventually become more affordable.
Is This the Future of Cholesterol Treatment?
The therapy is still undergoing clinical trials and may take years before regulatory approval. But many experts believe gene editing represents one of the most important advances in cardiovascular medicine in decades. For now, patients should continue their prescribed medications and lifestyle changes while researchers continue studying the long-term safety and effectiveness of this revolutionary treatment. As Dr. Rajneesh Kapoor concluded during the NDTV Profit interview, if gene-editing therapy proves safe and durable, it could become a historic breakthrough in the prevention of heart disease.
Share This News